AAA Robert Lavine – Page 44

EIP secures Access for series B round

Diversified conglomerate Access Industries has led a $20.5m series B round for EIP Pharma, a US-based company developing treatments for diseases affecting the central nervous system (CNS). Founded in 2014, EIP is working on drugs for CNS disorders, and in particular a small molecule inhibitor called neflamapimod that could potentially reverse the synaptic impairment associated… Continue reading EIP secures Access for series B round